Drug intelligence / Profile preview

VYC-12

Development stage
Unknown
Lead developer
AbbVie
Administration
Intradermal
01

Overview

VYC-12, marketed under the brand name Juvéderm Volite, is an injectable dermal filler developed by Allergan (now part of AbbVie) using the proprietary Vycross technology platform. It consists of a crosslinked hyaluronic acid (HA) gel that combines low and high molecular weight HA to achieve a high degree of crosslinking and cohesivity. Unlike traditional fillers designed for deep tissue volumization, VYC-12 is specifically intended for intradermal injection to improve skin quality by addressing superficial fine lines and enhancing hydration and elasticity. It acts within the extracellular matrix to bind water and provide structural support, with clinical effects lasting up to nine months for hydration and six months for skin smoothness.

Brand names
Juvéderm VoliteVolite
Other names
crosslinked hyaluronic acid gelVycross hyaluronic acid
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on VYC-12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VYC-12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call